From ipse dixit to evidence-based guidelines: On the optimal management of Tourette syndrome

European Journal of Paediatric Neurology

Volumn 16, Issue 3, 2012, Pages 310-311

  Cavanna, Andrea E ^a,b   Rickards, Hugh ^a   Worrall, Rhiannon ^c   Hoekstra, Pieter J ^d   Plessen, Kerstin J ^e   Roessner, Veit ^f  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZAMIDE DERIVATIVE; CLONIDINE; GUANFACINE; HALOPERIDOL; PIMOZIDE; RISPERIDONE; SULPIRIDE; TETRABENAZINE; TIAPRIDE;

ATTENTION DEFICIT DISORDER; CLINICAL ASSESSMENT; COMORBIDITY; CONSENSUS DEVELOPMENT; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; GILLES DE LA TOURETTE SYNDROME; HEALTH CARE ORGANIZATION; HEALTH SURVEY; HUMAN; LETTER; MEDICAL EXPERT; MEDICAL SOCIETY; MEDICAL SPECIALIST; NEUROLOGY; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; TARDIVE DYSKINESIA;

HUMANS; TOURETTE SYNDROME;

EID: 84859931731     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2012.01.010     Document Type: Letter

References (15)

1. Rickards H, Cavanna AE, Worrall R. Treatment practices in Tourette syndrome: the European perspective. Eur J Paediatr Neurol 2012, in press.
2. Eddy CM, Rickards H, Cavanna AE. Treatment strategies for tics in Tourette syndrome. Ther Adv Neurol Dis 2011;4:25-45.
3. Cavanna AE, Servo S, Monaco F, Robertson MM. The behavioral spectrum of Gilles de la Tourette syndrome. J Neuropsychiatry Clin Neurosci 2009;21:13-23.
4. Cath DC, Hedderly T, Ludolph AG, Stern JS, Murphy T, Hartmann A, et al. ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part I: assessment. Eur Child Adolesc Psychiatry 2011;20:155-71.
5. Roessner V, Plessen KJ, Rothenberger A, Ludolph AG, Rizzo R, Skov L, et al. ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment. Eur Child Adolesc Psychiatry 2011;20:173-96.
6. Verdellen C, van de Griendt J, Hartmann A, Murphy T, ESSTS Guidelines Group. European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry 2011;20:197-207.
7. Muller-Vahl KR, Cath DC, Cavanna AE, Dehning S, Porta M, Robertson MM, et al. European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation. Eur Child Adolesc Psychiatry 2011;20:209-17.
8. Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord 2011;26:1149-56.
9. Muller-Vahl KR, Roessner V, on behalf of the European Society for the Study of Tourette syndrome. Treatment of tics in patients with Tourette syndrome: recommendations according to the European Society for the Study of Tourette syndrome. Mov Disord 2011;26:2447.
10. Jankovic J, Kurlan R. Reply to: treatment of tics in patients with Tourette syndrome: recommendations according to the European Society for the Study of Tourette syndrome. Mov Disord 2011;26:2448.
11. Muller-Vahl KR, Krueger D. Does Tourette syndrome prevent tardive dyskinesia? Mov Disord 2011;26:2442-3.
12. Jankovic J, Clarence-Smith K. Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurother 2011;11:1509-23.
13. Cavanna AE, Pierce A, Rickards H. Atypical antipsychotics for Tourette syndrome. J Neurol Neurosurg Psychiatry 2011;82:-2. 15-16.
14. Scahill L, Gerald E, Berlin CM, Budman C, Coffey BJ, Jankovic J, et al. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx 2006;3:192-206. (Pubitemid 44061705)
15. Singer HS. Treatment of tics and Tourette syndrome. Curr Treat Options Neurol 2010;6:539-61.